Sapporo Holdings (2501) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Revenue increased 2.1% year-over-year to ¥385.6B, driven by strong beer sales in Japan, favorable overseas performance, and a weak yen.
Core operating profit fell 2.9% to ¥14.0B due to lower Food & Soft Drinks profits and higher IT investments, despite gains in Alcoholic Beverages and Real Estate.
Operating profit surged 84.6% to ¥17.7B, and profit attributable to owners rose 276.2% to ¥11.5B, reflecting asset sales and absence of prior-year impairment losses.
Annual outlook remains on track, with no revision to consolidated profit guidance.
Financial highlights
EBITDA rose 3.5% year-over-year to ¥30.4B; EBITDA margin improved.
Overseas revenue grew 7.2% to ¥96.5B; Real Estate EBITDA up 16.9% to ¥9.7B.
Cash and cash equivalents increased to ¥23.4B; net debt-to-equity ratio improved to 1.0x.
Free cash flow was ¥20.7B, supported by asset sales of ¥22.1B.
Total equity rose 10.8% year-over-year to ¥200.6B; ROE reached 5.5%.
Outlook and guidance
2024 revenue forecast revised upward to ¥526.0B; core operating profit guidance unchanged at ¥19.0B.
Real Estate segment profit forecast raised, Overseas Alcoholic Beverages lowered; consolidated profit plan unchanged.
ROE target for 2024 is 5.5%, with a medium-term goal of 8.0% by 2026.
Dividend forecast maintained at ¥52 per share for FY24.
Profit attributable to owners projected at ¥10.0B; EPS forecast at ¥128.37.
Latest events from Sapporo Holdings
- Record profits and ROE in 2025, with a major real estate gain projected for 2026.2501
Q4 202513 Feb 2026 - Core profit and EBITDA surged despite lower revenue; profit guidance raised, stock split planned.2501
Q3 202512 Nov 2025 - Core operating profit nearly doubled despite a 1.2% revenue decline and lower net profit.2501
Q2 20257 Aug 2025 - Strong profit recovery driven by beer sales, asset gains, and improved financial position.2501
Q2 202413 Jun 2025 - Revenue up, losses widen on impairments; profit and margin outlook strong.2501
Q1 20256 Jun 2025 - Core profit up 41%, net profit down on impairment; 2025 profit rebound expected.2501
Q4 20245 Jun 2025